newsfilter
← Latest News
GlobeNewswire·

Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates

NEW YORK and SANTA BARBARA, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (NASDAQ:PTIX) (the "Company") today announces that on July 18, 2025, the Japanese Patent Office granted Patent JP